Dr. Jeffrey R. Jay, M.D. »

Annexon shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Annexon (ANNX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Annexon

Tip: Access up to 7 years of quarterly data

All positions including Annexon held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annexon by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 2.5M 5.54

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Annexon

Redmile Group
BlackRock
FMR
BVF
Vanguard Group
Vanguard Capital Management
Adage Capital Partners GP
Bain Capital Life Sciences Investors
Bellevue Group
MAK Capital One
State Street Corporation
Nuveen
Balyasny Asset Management
Ameriprise Financial
Geode Capital Management

View all funds holding Annexon